HLA-C and tuberculosis: Among the HIV-1 infected individuals (Group 1 vs Group 2), not carrying KIR2DL3 [aOR = 0.18 (95% CI, 0.04–0.74), P = 0.034] and carrying HLA-C*07 ([aOR = 0.32 (95% CI, 0.11–0.94), P = 0.038] were associated with protection against TB onset (Table 2).